{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T06:05:19Z","timestamp":1792130719770,"version":"4.4.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,7,6]],"date-time":"2019-07-06T00:00:00Z","timestamp":1562371200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,7,6]],"date-time":"2019-07-06T00:00:00Z","timestamp":1562371200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100007219","name":"Natural Science Foundation of Shanghai","doi-asserted-by":"publisher","award":["81573581"],"award-info":[{"award-number":["81573581"]}],"id":[{"id":"10.13039\/100007219","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National S&T Major Special Projects","award":["2014ZX09301306-007"],"award-info":[{"award-number":["2014ZX09301306-007"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nat Med"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1007\/s11418-019-01334-3","type":"journal-article","created":{"date-parts":[[2019,7,6]],"date-time":"2019-07-06T18:10:27Z","timestamp":1562436627000},"page":"17-25","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Sweroside ameliorated carbon tetrachloride (CCl4)-induced liver fibrosis through FXR-miR-29a signaling pathway"],"prefix":"10.1007","volume":"74","author":[{"given":"Junting","family":"Gong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaoling","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowen","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangfang","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lieming","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengtao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5484-0895","authenticated-orcid":false,"given":"Li","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,6]]},"reference":[{"key":"1334_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1172\/JCI24282","volume":"115","author":"R Bataller","year":"2005","unstructured":"Bataller R, Brenner DA (2005) Liver fibrosis. J Clin Invest 115:209\u2013218","journal-title":"J Clin Invest"},{"key":"1334_CR2","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1016\/j.jhep.2011.09.024","volume":"56","author":"E Ellis","year":"2012","unstructured":"Ellis E, Mann DA (2012) Clinical evidence for the regression of liver fibrosis. J Hepatol 56:1171\u20131180","journal-title":"J Hepatol"},{"key":"1334_CR3","doi-asserted-by":"publisher","first-page":"25087","DOI":"10.18632\/oncotarget.7837","volume":"7","author":"ML Tornesello","year":"2016","unstructured":"Tornesello ML, Buonagur L, Izzo F, Buonaguro FM (2016) Molecular alterations in hepatocellular carcinoma associated with hepatitis B and hepatitis C infections. Oncotarget 7:25087\u201325102","journal-title":"Oncotarget"},{"key":"1334_CR4","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.jhep.2014.07.035","volume":"62","author":"L Chen","year":"2015","unstructured":"Chen L, Li J, Zhang J, Dai C, Liu X, Wang J, Gao Z, Guo H, Wang R, Lu S, Wang F, Zhang H, Chen H, Fan X, Wang S, Qin Z (2015) S100A4 promotes liver fibrosis via activation of hepatic stellate cells. J Hepatol 62:156\u2013164","journal-title":"J Hepatol"},{"issue":"1206\u20131217","key":"1334_CR5","first-page":"e1207","volume":"142","author":"CG Lee","year":"2012","unstructured":"Lee CG, Kim YW, Kim EH, Meng Z, Huang W, Hwang SJ, Kim SG (2012) Farnesoid X receptor protects hepatocytes from injury by repressing miR-199a-3p, which increases levels of LKB1. Gastroenterology 142(1206\u20131217):e1207","journal-title":"Gastroenterology"},{"key":"1334_CR6","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/j.jhep.2012.11.022","volume":"58","author":"C Roderburg","year":"2013","unstructured":"Roderburg C, Luedde M, Cardenas DV, Vucur M, Mollnow T, Zimmermann HW, Koch A, Hellerbrand C, Weiskirchen R, Frey N, Tacke T, Trautwein C, Luedde T (2013) miR-133a mediates TGF-beta-dependent derepression of collagen synthesis in hepatic stellate cells during liver fibrosis. J Hepatol 58:736\u2013742","journal-title":"J Hepatol"},{"key":"1334_CR7","doi-asserted-by":"publisher","first-page":"3199","DOI":"10.1002\/jcb.26475","volume":"119","author":"R Tao","year":"2017","unstructured":"Tao R, Fan XX, Yu HJ, Ai G, Zhang HY, Kong HY, Song QQ, Huang Y, Huang JQ, Ning Q (2017) MicroRNA-29b-3p prevents Schistosoma japonicum-induced liver fibrosis by targeting COL1A1 and COL3A1. J Cell Biochem 119:3199\u20133209","journal-title":"J Cell Biochem"},{"key":"1334_CR8","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1124\/mol.110.068247","volume":"80","author":"J Li","year":"2011","unstructured":"Li J, Zhang Y, Kuruba R, Gao X, Gandhi CR, Xie W, Li S (2011) Roles of microRNA-29a in the antifibrotic effect of farnesoid X receptor in hepatic stellate cells. Mol Pharmacol 80:191\u2013200","journal-title":"Mol Pharmacol"},{"key":"1334_CR9","doi-asserted-by":"publisher","first-page":"2647","DOI":"10.1111\/j.1582-4934.2012.01578.x","volume":"16","author":"T Kogure","year":"2012","unstructured":"Kogure T, Costinean S, Yan I, Braconi C, Croce C, Patel T (2012) Hepatic miR-29ab1 expression modulates chronic hepatic injury. J Cell Mol Med 16:2647\u20132654","journal-title":"J Cell Mol Med"},{"key":"1334_CR10","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1124\/jpet.105.085597","volume":"315","author":"S Fiorucci","year":"2005","unstructured":"Fiorucci S, Rizzo G, Antonelli E, Renga B, Mencarelli A, Riccardi L, Morelli A, Pruzanski M, Pellicciari R (2005) Cross-talk between farnesoid-X-receptor (FXR) and peroxisome proliferator-activated receptor gamma contributes to the antifibrotic activity of FXR ligands in rodent models of liver cirrhosis. J Pharmacol Exp Ther 315:58\u201368","journal-title":"J Pharmacol Exp Ther"},{"key":"1334_CR11","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.biopha.2017.08.007","volume":"95","author":"XL Han","year":"2017","unstructured":"Han XL, Li JD, Wang WL, Yang C, Li ZY (2017) Sweroside eradicated leukemia cells and attenuated pathogenic processes in mice by inducing apoptosis. Biomed Pharmacother 95:477\u2013486","journal-title":"Biomed Pharmacother"},{"key":"1334_CR12","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1016\/j.foodchem.2017.08.049","volume":"240","author":"J Oszmia\u0144ski","year":"2018","unstructured":"Oszmia\u0144ski J, Kucharska AZ (2018) Effect of pre-treatment of blue honeysuckle berries on bioactive iridoid content. Food Chem 240:1087\u20131091","journal-title":"Food Chem"},{"key":"1334_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jep.2011.08.016","volume":"138","author":"X Shang","year":"2011","unstructured":"Shang X, Pan H, Li M, Miao X, Ding H (2011) Lonicera japonica Thunb.: ethnopharmacology, phytochemistry and pharmacology of an important traditional Chinese medicine. J Ethnopharmacol 138:1\u201321","journal-title":"J Ethnopharmacol"},{"key":"1334_CR14","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1021\/jf803015s","volume":"57","author":"C Brownmiller","year":"2009","unstructured":"Brownmiller C, Howard LR, Prior RL (2009) Processing and storage effects on procyanidin composition and concentration of processed blueberry products. J Agric Food Chem 57:1896\u20131902","journal-title":"J Agric Food Chem"},{"key":"1334_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2202\/1556-3758.1683","volume":"5","author":"C Liu","year":"2009","unstructured":"Liu C, Zheng X, Jia S, Ding N, Gao X (2009) Comparative experiment on hot air and microwave-vacuum drying and puffing of blue honeysuckle snack. Int J Food Eng 5:1\u20139","journal-title":"Int J Food Eng"},{"key":"1334_CR16","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.jpba.2010.03.015","volume":"53","author":"C Sun","year":"2010","unstructured":"Sun C, Teng Y, Li G, Yoshioka S, Yokota J, Miyamura M, Fang H, Zhang Y (2010) Metabonomics study of the protective effects of Lonicera japonica extract on acute liver injury in dimethylnitrosamine treated rats. J Pharm Biomed 53:98\u2013102","journal-title":"J Pharm Biomed"},{"key":"1334_CR17","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.intimp.2012.10.017","volume":"15","author":"CC Yang","year":"2013","unstructured":"Yang CC, Fang JY, Hong TL, Wang TC, Zhou YE, Lin TC (2013) Potential antioxidant properties and hepatoprotective effects of an aqueous extract formula derived from three Chinese medicinal herbs against CCl4-induced liver injury in rats. Int Immunopharmacol 15:106\u2013113","journal-title":"Int Immunopharmacol"},{"key":"1334_CR18","doi-asserted-by":"crossref","first-page":"75165","DOI":"10.18632\/oncotarget.12614","volume":"7","author":"F Yang","year":"2016","unstructured":"Yang F, Gong J, Wang G, Chen P, Yang L, Wang Z (2016) Waltonitone inhibits proliferation of hepatoma cells and tumorigenesis via FXR-miR-22-CCNA2 signaling pathway. Oncotarget 7:75165\u201375175","journal-title":"Oncotarget"},{"key":"1334_CR19","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.cbi.2015.05.022","volume":"238","author":"YT Jeong","year":"2015","unstructured":"Jeong YT, Jeong SC, Hwang JS, Kim JH (2015) Modulation effects of sweroside isolated from the Lonicera japonica on melanin synthesis. Chem Biol Interact 238:33\u201339","journal-title":"Chem Biol Interact"},{"key":"1334_CR20","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1002\/iub.1492","volume":"68","author":"W Xu","year":"2016","unstructured":"Xu W, Lu C, Zhang F, Shao J, Zheng S (2016) Dihydroartemisinin restricts hepatic stellate cell contraction via an FXR-S1PR2-dependent mechanism. IUBMB Life 68:376\u2013387","journal-title":"IUBMB Life"},{"key":"1334_CR21","doi-asserted-by":"publisher","first-page":"2286","DOI":"10.1002\/hep.26939","volume":"59","author":"L Verbeke","year":"2014","unstructured":"Verbeke L, Farre R, Trebicka J, Komuta M, Roskams T, Klein S, Elst IV, Windmolders P, Vanuytsel T, Nevens F, Laleman W (2014) Obeticholic acid, a farnesoid X receptor agonist, improves portal hypertension by two distinct pathways in cirrhotic rats. J Hepatol 59:2286\u20132298","journal-title":"J Hepatol"},{"key":"1334_CR22","doi-asserted-by":"publisher","first-page":"e13955","DOI":"10.1371\/journal.pone.0013955","volume":"5","author":"J Li","year":"2010","unstructured":"Li J, Kuruba R, Wilson A, Gao X, Zhang Y, Li S (2010) Inhibition of endothelin-1-mediated contraction of hepatic stellate cells by FXR ligand. PLoS One 5:e13955","journal-title":"PLoS One"},{"key":"1334_CR23","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/jms.3429","volume":"49","author":"H Han","year":"2014","unstructured":"Han H, Zeng W, He C, Bligh A, Liu Q, Yang L, Wang ZT (2014) Characterization of metabolites of sweroside in rat urine using ultra-high-performance liquid chromatography combined with electrospray ionization quadrupole time-of-flight tandem mass spectrometry and NMR spectroscopy. J Mass Spectrom 49:11","journal-title":"J Mass Spectrom"},{"key":"1334_CR24","doi-asserted-by":"publisher","first-page":"12604","DOI":"10.1074\/jbc.M109.094524","volume":"285","author":"J Lee","year":"2010","unstructured":"Lee J, Padhye A, Sharma A, Song G, Miao J, Mo YY, Wang L, Kemper JK (2010) A pathway involving farnesoid X receptor and small heterodimer partner positively regulates hepatic sirtuin 1 levels via microRNA-34a inhibition. J Biol Chem 285:12604\u201312611","journal-title":"J Biol Chem"},{"key":"1334_CR25","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s12943-015-0427-9","volume":"14","author":"J He","year":"2015","unstructured":"He J, Zhao K, Zheng L, Xu Z, Gong W, Chen S, Shen X, Huang G, Gao M, Zeng Y, Zhang Y, He F (2015) Upregulation of microRNA-122 by farnesoid X receptor suppresses the growth of hepatocellular carcinoma cells. Mol Cancer 14:163","journal-title":"Mol Cancer"},{"key":"1334_CR26","doi-asserted-by":"publisher","first-page":"6507","DOI":"10.1074\/jbc.M114.620369","volume":"290","author":"F Yang","year":"2015","unstructured":"Yang F, Hu Y, Liu HX, Wan YL (2015) MiR-22-silenced cyclin A expression in colon and liver cancer cells is regulated by bile acid receptor. J Biol Chem 290:6507\u20136515","journal-title":"J Biol Chem"},{"key":"1334_CR27","doi-asserted-by":"publisher","first-page":"e115596","DOI":"10.1371\/journal.pone.0115596","volume":"9","author":"M Ciechomska","year":"2014","unstructured":"Ciechomska M, O\u2019Reilly S, Suwara M, Bogunia-Kubik K, Van Laar JM (2014) MiR-29a reduces TIMP-1 production by dermal fibroblasts via targeting TGF-beta activated kinase 1 binding protein 1, implications for systemic sclerosis. PLoS One 9:e115596","journal-title":"PLoS One"},{"key":"1334_CR28","doi-asserted-by":"publisher","first-page":"P1848","DOI":"10.1038\/mt.2016.127","volume":"24","author":"Y Matsumoto","year":"2016","unstructured":"Matsumoto Y, Itami S, Kuroda M, Yoshizato K, Kawada N, Murakami Y (2016) MiR-29a assists in preventing the activation of human stellate cells and promotes recovery from liver fibrosis in mice. Mol Ther 24:P1848\u2013P1859","journal-title":"Mol Ther"},{"key":"1334_CR29","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1093\/infdis\/jir186","volume":"203","author":"S Bandyopadhyay","year":"2011","unstructured":"Bandyopadhyay S, Friedman RC, Marquez RT, Keck K, Kong B, Icardi MS, Brown KE, Burge CB, Schmidt WN, Wang Y, McCaffrey AP (2011) Hepatitis C virus infection and hepatic stellate cell activation downregulate miR-29: miR-29 overexpression reduces hepatitis C viral abundance in culture. J Infect Dis 203:1753\u20131762","journal-title":"J Infect Dis"},{"key":"1334_CR30","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1016\/j.bbrc.2018.01.132","volume":"496","author":"YC Lin","year":"2018","unstructured":"Lin YC, Wang FS, Yang YL, Chuang YT, Huang YH (2018) MicroRNA-29a mitigation of toll-like receptor 2 and 4 signaling and alleviation of obstructive jaundice-induced fibrosis in mice. Biochem Bioph Res Co 496:880\u2013886","journal-title":"Biochem Bioph Res Co"},{"key":"1334_CR31","doi-asserted-by":"publisher","first-page":"5237","DOI":"10.1182\/blood-2008-11-189407","volume":"113","author":"B Stamatopoulos","year":"2009","unstructured":"Stamatopoulos B, Meuleman N, Haibe-Kains B, Saussoy P, Neste EVD, Michaux L, Heimann P, Martiat P, Bron D, Lagneaux L (2009) MicroRNA-29c and microRNA-223 down-regulation has in vivo significance in chronic lymphocytic leukemia and improves disease risk stratification. Blood 113:5237\u20135245","journal-title":"Blood"},{"key":"1334_CR32","first-page":"836","volume":"51","author":"Y Xiong","year":"2010","unstructured":"Xiong Y, Fang JH, Yun JP, Yang J, Zhang Y, Jia WH, Zhuang SM (2010) Effects of microRNA-29 on apoptosis, tumorigenicity, and prognosis of hepatocellular carcinoma. J Hepatol 51:836\u2013845","journal-title":"J Hepatol"},{"key":"1334_CR33","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1038\/aps.2016.86","volume":"37","author":"QL Yang","year":"2016","unstructured":"Yang QL, Yang F, Gong JT, Tang XW, Wang GY, Wang ZT, Yang L (2016) Sweroside ameliorates alpha-naphthylisothiocyanate-induced cholestatic liver injury in mice by regulating bile acids and suppressing pro-inflammatory responses. Acta Pharmacol Sin 37:1218\u20131228","journal-title":"Acta Pharmacol Sin"}],"container-title":["Journal of Natural Medicines"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11418-019-01334-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11418-019-01334-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11418-019-01334-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,4]],"date-time":"2020-07-04T23:20:22Z","timestamp":1593904822000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11418-019-01334-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,6]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["1334"],"URL":"https:\/\/doi.org\/10.1007\/s11418-019-01334-3","relation":{},"ISSN":["1340-3443","1861-0293"],"issn-type":[{"value":"1340-3443","type":"print"},{"value":"1861-0293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,6]]},"assertion":[{"value":"25 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}